Trials / Unknown
UnknownNCT03944083
Children With ADHD and Emotional Dysregulation
Emotional Dysregulation in Children With Attention Deficit Hyperactivity Disorder (ADHD)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Oslo University Hospital · Academic / Other
- Sex
- All
- Age
- 6 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
Studies have shown that children with Attention Deficit Hyperactivity Disorder (ADHD) and emotional dysregulation are characterized by high severity of ADHD, comorbid behavior disorders and increased risk of chronic difficulties. New studies have shown promising results by focusing on improving emotional regulation. We lack knowledge about differences in symptom patterns, stability of symptoms over time, comorbid disorders, neurocognitive functions, knowledge and regulation of emotions, psychosocial risk factors and reactions to stress. Children 6 to 12 years admitted to specialist and diagnosed with ADHD will be recruited. ADHD children with and without emotional dysregulation defined as fullfilling the criteria for the diagnosis Disruptive Mood Dysregulation Disorder (DMDD) with regard to differences in symptom patterns, stability of symptoms over time, comorbid disorders, neurocognitive functions, knowledge and regulation of emotions, psychosocial risk factors and reactions to stress..
Detailed description
Children referred to outpatient psychiatric service will be informed about the study and asked to participate. The clinical assessments in the study will be those that are recommended as good clinical practice, so results will be included in the diagnostic work for the patient. The data security will follow the Norwegian rules and be monitored by REC and the Data Inspectorate of the hospital.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Treatment as usual for ADHD | Children are given treatment according to diagnostic conclusion and clinical recommendations. |
Timeline
- Start date
- 2019-06-01
- Primary completion
- 2021-08-01
- Completion
- 2021-08-01
- First posted
- 2019-05-09
- Last updated
- 2019-05-13
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT03944083. Inclusion in this directory is not an endorsement.